Phase I trial of oxaliplatin plus S-1 chemotherapy in patients with metastatic colorectal cancer. - Wikidata - awgldk - TriplyDB

Phase I trial of oxaliplatin plus S-1 chemotherapy in patients with metastatic colorectal cancer.

Phase I trial of oxaliplatin plus S-1 chemotherapy in patients with metastatic colorectal cancer.

http://www.wikidata.org/entity/Q33403227

about

Phase I trial of oxaliplatin plus S-1 chemotherapy in patients with metastatic colorectal cancer.

http://www.wikidata.org/entity/Q33403227

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Phase I trial of oxaliplatin p ...... metastatic colorectal cancer.

@ast

Phase I trial of oxaliplatin p ...... metastatic colorectal cancer.

@en

type

label

Phase I trial of oxaliplatin p ...... metastatic colorectal cancer.

@ast

Phase I trial of oxaliplatin p ...... metastatic colorectal cancer.

@en

prefLabel

Phase I trial of oxaliplatin p ...... metastatic colorectal cancer.

@ast

Phase I trial of oxaliplatin p ...... metastatic colorectal cancer.

@en

P1433

Q33403227-534CB3F0-CBEB-4A3B-8D7F-C87E54589434

P1476

Q33403227-5362B103-A2CC-4516-82B1-A5FA7DB5C03D

P2093

Q33403227-38481D02-CEF5-42F1-AFDB-FA8FC6E4DCD0

Q33403227-5820234A-3581-4A11-8C7A-AD2725739FB1

Q33403227-6A2D7EE6-BCB4-4447-B057-E6BBBC3CE8CF

Q33403227-730B1D68-5AD2-47AC-8D75-C082E7010B69

Q33403227-D0D0D078-A405-4B33-98EF-F9F3DA8F3F33

P2860

Q33403227-1E71DDEE-F165-4C49-99CB-82F7415C9C92

Q33403227-398C6DDC-A8DF-4E56-958E-4A180CBC0859

Q33403227-448D64DD-B24A-4AB3-B033-73EB8AE87C3C

Q33403227-6FA47CB6-6EB5-4FB9-B944-4CF1F976593F

Q33403227-8AC11236-8113-4E04-AA95-63AED838E4A4

Q33403227-987A97F9-8B72-41C7-99A6-4AA09FD6E323

Q33403227-9F2E229A-C896-4083-8F15-C7965D5620AE

Q33403227-A7713755-B386-4467-A5B3-8F3D8185ABE6

Q33403227-AB115CBA-616C-409A-B9CF-8CA90AF05A75

Q33403227-B316BC35-F886-4FF1-BB2D-B7FFA43EF3DA

P304

Q33403227-90FFB87A-C886-4C6B-B1AC-2A753D51A5E6

P31

Q33403227-899B4CB3-AAF3-4DB3-A72B-E80D8E5754F0

P356

Q33403227-590225D2-F1D5-4E2D-884E-27C5139E3FEA

P433

Q33403227-C89A6A0F-C299-49E6-8591-D613DFDD869F

P478

Q33403227-89721FFF-B497-452A-B58E-6229ADBF6449

P577

Q33403227-E1CCEC6E-2E82-4233-9B03-FE0908505FFD

P5875

Q33403227-1D139BF5-ECCD-48CA-817A-1A144B0484AB

P698

Q33403227-E7F63B60-BAEA-40F3-83F0-06B80B04F0D9

P921

Q33403227-A666C7ED-8F87-479F-B67D-95B6CBB34B25

Q33403227-E25B5DDF-BF01-463B-A177-97446D8E659B

P932

Q33403227-8F453947-7687-4650-AA1D-6E81E6AFB05E

P356

P1433

Oncology Letters

P1476

Phase I trial of oxaliplatin p ...... metastatic colorectal cancer.

@en

P2093

Jun Hihara

http://www.w3.org/2001/XMLSchema#string

Katsuji Hironaka

http://www.w3.org/2001/XMLSchema#string

Manabu Emi

http://www.w3.org/2001/XMLSchema#string

Morihito Okada

http://www.w3.org/2001/XMLSchema#string

Yoshiyuki Yamaguchi

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer.

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer.

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer.

Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.

Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group

EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancer.

Plasma concentrations of 5-fluorouracil and F-beta-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil.

Phase I study with pharmacokinetics of S-1 on an oral daily schedule for 28 days in patients with solid tumors.

P304

95-98

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL_00000017

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230830764

http://www.w3.org/2001/XMLSchema#string

P698

22966263

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

phase I clinical trial

P932

3436359

http://www.w3.org/2001/XMLSchema#string